Randomized trial demonstrates improved COPD detection via integrated CT biomarkers in lung cancer screening participants, suggesting more efficient spirometry referrals.
BACKGROUND: Lung cancer screening offers an opportunity to enhance COPD detection among adults exposed to tobacco smoke; however, guidance on CT scan-based referral for spirometry is limited. RESEARCH QUESTION: Which low-dose CT scan emphysema threshold best identifies previously undiagnosed COPD in lung cancer screening patients, and does the addition of quantitative airway biomarkers enhance detection? STUDY DESIGN AND METHODS: /FVC was additionally performed. RESULTS: Among 5,014 screening patients with available spirometry, 1,115 had previously undiagnosed COPD, corresponding to a prevalence of 22.2%. In patients without known airway disease, emphysema alone at an optimized threshold of 5.1% showed moderate performance for COPD detection (area under the receiver operating characteristic curve [AUC], 0.69; 95% CI, 0.67-0.72; accuracy, 66%; positive predictive value [PPV], 44%), where 41% of patients exceeded this threshold and met criteria for confirmatory spirometry. An integrated model combining emphysema, standardized square root wall area of airways with a theoretical internal perimeter of 10 mm, airway branch count, and clinical characteristics significantly improved detection (AUC, 0.83; 95% CI, 0.80-0.86; accuracy, 78%; PPV, 59%) while reducing the proportion requiring confirmatory spirometry to 34%. In a sensitivity analysis using the lower limit of normal definition of COPD, the best-performing model achieved an AUC of 0.86 (95% CI, 0.83-0.89), accuracy of 84%, and PPV of 53%, while referring 22% for confirmatory spirometry. INTERPRETATION: Our results show that an integrated approach combining CT scan-derived airway biomarkers and clinical characteristics enables more efficient and targeted COPD detection within lung cancer screening programs. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT04913155; URL: www. CLINICALTRIALS: gov.
No takes yet. Share an insight, caveat, or question.
Abdo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: